Greek National Organization of Medicines Approves First Antimicrobial Formula for Residual Surface Protection Against SARS-CoV-2 (COVID-19 Virus) for up to 90 Days

PHILADELPHIA–(BUSINESS WIRE) – ViaClean Technologies, LLC, a Philadelphia-based biotech company, together with its sales and business development partner Bizos Cavallo Enterprises LLC of Dallas, TX and partner, V-Clean Technologies SA of Athens, Greece, jointly announced the Approval country in Greece for the use of BIOPROTECT ™ RTU on porous and non-porous surfaces in the fight against SARS-CoV-2. Greece has recognized that BIOPROTECTTM RTU inhibits the growth of harmful bacteria and viruses, including SARS-CoV-2 (COVID virus), on surfaces for up to 90 days.

After the antimicrobial surface effectiveness of BIOPROTECT ™ RTU was accepted and recognized, the Greek National Organization for Medicinal Products (ΕΟΦ) approved the unrestricted use of BIOPROTECT ™ RTU by consumers to inhibit the growth of SARS-CoV-2 and other harmful viruses, bacteria, molds , and mold on treated surfaces. This innovative technology has been shown to be effective for up to 90 days and has been used in various public and private settings in Greece including medical facilities, local transportation, educational institutions, commercial establishments and more.

“ViaClean made a commitment over the past year to help reopen Europe in the hope of bringing people a sense of normalcy in these unprecedented times,” said Greg Tipsord, President and CEO of ViaClean. “With the introduction of the antimicrobial surface protectant BIOPROTECTTM RTU by Greece, which inhibits the growth of SARS-CoV-2 and other harmful viruses and bacteria on surfaces, we believe Greece will benefit from this proven technology and strengthen its commitment to being a pre- Pandemic levels of normalcy for their citizens. We have delivered an effective antimicrobial surface protection solution that supports our mission of continuous research, innovation and commitment on a global scale. ”

“At V-Clean Technologies SA we have continued our commitment to Greece and the continued safety of our fellow citizens and visitors through our commitment to bring innovative, patented technologies to our country to reduce the presence of bacteria, germs, fungi and algae solidified, and other problematic microorganisms, including SARS CoV-2, “said Panos Sofianos, President of V-Clean.” We thank the Greek government and in particular the Ministry of Health and the National Organization for Medicines (ΕΟΦ), our joint venture distributor Bizos Cavallo Enterprises and of course ViaClean Technologies for their rigor, care and support during this process. ”

In Greece and other European member states pending regulatory approvals, the unique non-leaching and non-volatile BIOPROTECTTM RTU formula has been shown to be effective in killing harmful microbes and reducing odors on various surfaces for up to 90 days. “We are happy and excited to have partnered with V-Clean Technologies and ViaClean Technologies by facilitating the approval process and distribution of the antimicrobial surface protection agent BIOPROTECTTM RTU for Greece,” said Elvin Thibodeaux, Managing Partner of Bizos Cavallo Enterprises. “Our continued efforts will exclusively deliver this innovative technology to additional markets including the European Union and the Balkans, Russia and others that have been seeking dynamic pandemic relief over the past 18 months.”

In the USA, ViaClean markets the BIOPROTECTUs ™ system, which uses patented, registered technologies: SmartTouch®, a list N disinfectant to disinfect surfaces against viruses, bacteria and germs, and BIOPROTECT ™ RTU antimicrobial surface protection agent to keep surfaces free from Odor and stain causing bacteria, fungi (mold and mildew) and algae between cleanings for up to 90 days (3 months). However, in the United States, BIOPROTECT ™ RTU is not currently approved or available for use against the SARS-CoV-2 virus, other viruses, harmful bacteria, or other harmful microorganisms.

Other products offered by ViaClean and Bizos Cavallo in the USA and pending approval in Greece include the registered BIOPROTECT ™ 500 concentrate, the registered BIOPROTECTTM D disinfectant and the registered BIOPROTECT ™ Hydrating Hand Sanitizer. For more information on ViaClean Technologies and the BIOPROTECTUs ™ system, please visit bioprotectworldwide.com. For information on the above markets or sales with Bizos Cavallo Enterprises, please visit www.bizoscavallo.com.

Via ViaClean technologies. GMBH

ViaClean Technologies LLC is a biotech company that develops, manufactures and markets groundbreaking, innovative antimicrobial solutions using environmentally sound manufacturing processes. ViaClean Technologies’ groundbreaking and proprietary technologies, products, and services provide disinfectants, antimicrobial protectants, and hand sanitizers for commercial and consumer use. ViaClean Technologies’ main role is to market these advanced antimicrobial formulations to critical industries and to manufacture the registered formulations using environmentally sound processes. For more information, see the ViaClean website (bioprotectworldwide.com).

About V-Clean Technologies, SA

V-Clean Technologies SA is a biotechnology company based in Athens, Greece focused on developing and commercializing cutting edge technologies, products and services to meet the challenges and opportunities in Europe, Russia and the Middle East. In conjunction with our pharmaceutical subsidiaries and partners, we strive for innovative and environmentally friendly solutions in a constantly changing market. Since we have created a strong and sustainable network of strategic partners in these regions, we are able to proactively and effectively offer services ranging from manufacturing, procurement, logistics and regulatory advice. For more information about V-Clean Technologies SA please visit our website (www.virusclean.gr).

About Bizos Cavallo Enterprises, LLC

Bizos Cavallo Enterprises, LLC is a strategic consulting and operations company focused on emerging public health life science innovations, strategic alliances and global investment resources based in Dallas, TX with offices in New Orleans, LA and Winston-Salem, NC concentrated. In addition, Bizos Cavallo owns the subsidiary BP&D International, LLC, a global leader in the procurement and export of high value cultural goods, including grains, animal proteins and their derivatives. The Bizos Cavallo network, founded in 2017, includes partners and a variety of strategic alliances in the US, Greece, China, South Korea, Japan, Singapore, Dubai, France, Brazil, the West Indies and trading operations in the United Kingdom. For more information about Bizos Cavallo, please visit the Bizos Cavallo Enterprises website (www.bizoscavallo.com).

[ad_1]